Welcome to our investor pages
Medical technology company Optomed is leading producer of handheld fundus cameras globally.
- Net sales 13,0 EUR, million
- Gross margin 68.8 %
- Adjusted EBITDA -0.7 EUR, million
- Equity ratio 64.6 %
Share Price
Nasdaq Helsinki Stock Exchange
Latest releases
Next IR events
Nov 4
- Nov 4, 2021
Optomed will publish Q3-2021 Interim Report
Nov 11
- Nov 11, 2021
Redeye Life Science Day
Feb 17
- Feb 17, 2022
Optomed Plc will release its Financial Statement Bulletin for 1 January – 31 December 2021
May 5
- May 5, 2022
Optomed Plc will release its Interim Report for 1 January – 31 March 2021
Aug 4
- Aug 4, 2022
Optomed Plc will release its Half-Year Financial Report for 1 January – 30 June 2022
Nov 3
- Nov 3, 2022
Optomed Plc will release its Interim Report for 1 January – 30 September 2022
Optomed as an investment
Optomed is a research and development as well as sales driven medical technology company in expansion phase.
Optomed is one of the leading players in the growing and transforming handheld fundus camera market.
Read more
